Sanrai Med India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.50 M
as on 24-10-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -63.33%
(FY 2023)
- Profit -89.27%
(FY 2023)
- Ebitda -228.53%
(FY 2023)
- Net Worth 4.65%
(FY 2023)
- Total Assets -49.11%
(FY 2023)
About Sanrai Med India
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Himmat Sandhu and Jaspreet Rai serve as directors at the Company.
- CIN/LLPIN
U24233CH2007PTC031602
- Company No.
031602
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sanrai Med India Private Limited. offer?
Sanrai Med India Private Limited. offers a wide range of products and services, including Surgical & ICU Equipments, Oxygen Mask, CPAP, BiPAP Machine & Accessories, BiPAP Machine, Oxygen Concentrator, Invacare Oxygen Concentrator, Electrodiagnostic Instruments, Medical Diagnostic Equipment, Patient Monitoring System, Cardiac & Multi Parameter Patient Monitor.
Who are the key members and board of directors at Sanrai Med India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himmat Sandhu  | Additional Director | 30-Jun-2022 | Current |
| Jaspreet Rai | Director | 01-Jan-2009 | Current |
Financial Performance of Sanrai Med India.
Sanrai Med India Private Limited., for the financial year ended 2023, experienced significant reduction in revenue, with a 63.33% decrease. The company also saw a substantial fall in profitability, with a 89.27% decrease in profit. The company's net worth moved up by a moderate rise of 4.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanrai Med India?
In 2023, Sanrai Med India had a promoter holding of 73.39% and a public holding of 26.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ascentx Software Development Services Private LimitedActive 18 years 10 monthsHimmat Sandhu and Jaspreet Rai are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanrai Med India?
Sanrai Med India has a workforce of 80 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanrai Med India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanrai Med India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
